Factor XIII and the clotting of fibrinogen: from basic research to medicine.
about
The fibrinogen Aalpha R16C mutation results in fibrinolytic resistanceThe role of saliva in tick feedingStructure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulantsStrain history dependence of the nonlinear stress response of fibrin and collagen networks.Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.Site-specific protein propargylation using tissue transglutaminase.The effect of fibrinogen concentrate on thrombocytopenia.Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation.Factor XIII: recommended terms and abbreviations.Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: relevance for erythrocyte diseases with shortened cell lifespan.Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.Acquired FXIII inhibitors: a systematic review.Diagnosis of factor XIII deficiency.Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.A constitutive model for the time-dependent, nonlinear stress response of fibrin networks.Reversible activation of cellular factor XIII by calcium.Synthesis and functional characterization of tridegin and its analogues: inhibitors and substrates of factor XIIIa.Interferon-γ, interleukins-6 and -4, and factor XIII-A as indirect markers of the classical and alternative macrophage activation pathways in chronic periodontitis.Association of perioperative factor XIII activity levels and other haemostatic markers with the risk of postoperative intracranial haematoma in a selected cohort of neurosurgical patients.Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.Coagulation factor XIII variants with altered thrombin activation rates.Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin.
P2860
Q24297406-45C45E1A-9DB4-46B8-BF53-F56D171A61AEQ27490448-2CC6A210-8896-4221-9999-C916DDCC9587Q27687108-1899982C-43B9-44BD-914C-4A631E1C03AAQ30541840-7CAB810A-B817-4729-9559-D4A3B2F911AEQ30997344-9F88D659-7EB4-4490-93C6-6BAE3028A139Q31063390-1910E3A2-B341-46B0-B4B8-BF4608284505Q33375024-122D591F-61CC-4B6B-AC68-F1A5AAD148FCQ33959050-E62ADA78-CFB4-409E-A545-E5330A76481FQ34561268-649A90AA-6211-4779-89B0-DED91D76AFBEQ35856363-A4239E08-CDC0-4016-89E4-F471D9B837B4Q37259580-2C86829C-36E4-4C9B-9F75-6CB3B2114160Q38052068-9FF22FB6-3D96-4242-A473-9655C36B8A83Q38808158-C399106C-B001-4686-BC09-A86D2419A2CBQ41791459-BB54A6FD-DFB9-4EBD-B3A5-66C5F575CB24Q41825512-83D85318-B98C-4947-9B21-A4425E08AE68Q41967637-6CDF0227-3514-4384-B147-03561724FC4BQ42103946-0BB44E1D-50AF-4AE0-BB33-707D74DE47DAQ44510667-4DF22D19-4D39-4EE4-ABE5-CAB747872ACBQ45207763-467020EF-A1A9-4946-ACB7-E9A134801FB2Q48643585-5E163607-0C21-4758-B8F3-1B40BC473F6FQ51015788-9F6A0055-46BC-48C2-9D74-2B36BCFEF9D1Q53367600-D69FD7A5-AA56-44EA-8367-0FD60D9B480FQ53589389-5F4E1506-A2C3-4253-9808-5A829B6AB36C
P2860
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
@ast
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
@en
type
label
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
@ast
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
@en
prefLabel
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
@ast
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
@en
P2860
P1476
Factor XIII and the clotting of fibrinogen: from basic research to medicine.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2005.01213.X
P577
2005-07-01T00:00:00Z